BDBM800620 (S)-5-(4-((2- ((4-((3-(oxazol- 5-ylmethyl)-5- (trifluoromethoxy) benzyl)ami- no)pentyl)oxy) ethyl)amino)- 1H-indazol-6- yl)pyridazin-3- ol::(S)-5-(4-((2-((4-((3-(oxazol-5-ylmethyl)-5-(trifluoromethoxy)benzyl)amino)pentyl)oxy)ethyl)amino)-1H-indazol-6-yl)pyridazin-3-ol ::US20260085062, Example 195

SMILES C[C@@H](CCCOCCNc1cc(-c2cnnc(O)c2)cc2[nH]ncc12)NCc1cc(Cc2cnco2)cc(OC(F)(F)F)c1

InChI Key InChIKey=YQFSAIVJWUOYAN-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 800620   

TargetCasein kinase II subunit alpha(Human)
Cambridge Enterprise

US Patent
LigandChemical structure of BindingDB Monomer ID 800620BDBM800620((S)-5-(4-((2- ((4-((3-(oxazol- 5-ylmethyl)-5- (tri...)
Affinity DataIC50: 0.410nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7.5, 200 mM NaCl,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/5/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK2(Human)
Cambridge Enterprise

US Patent
LigandChemical structure of BindingDB Monomer ID 800620BDBM800620((S)-5-(4-((2- ((4-((3-(oxazol- 5-ylmethyl)-5- (tri...)
Affinity DataIC50: 227nMAssay Description:The assay was conducted in the same way as described for CK2α, with final assay conditions comprising 20 nM CLK2 (Carna Biosciences-04-127), 50 μM pe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/5/2026
Entry Details
US Patent